×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Thomas, McNerney & Partners II, LLC

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CRXTClarus Therapeutics Holdings, Inc.Thomas, McNerney & Partners II, LLC10% OwnerApr 20, 2022Sale$2.533,752,9129,494,867958,989Apr 25, 2022, 05:17 PM
CRXTCLARUS THERAPEUTICS INCThomas, McNerney & Partners II, LLC10% OwnerApr 20, 2022Sale$2.533,752,9129,494,867958,989Apr 21, 2022, 07:04 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerApr 18, 2019Option Exercise$2.4281,950198,45943,944Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerApr 18, 2019Option Exercise$2.42231,719560,889119,872Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerApr 18, 2019Option Exercise$2.4223,009,33555,719,61312,300,186Apr 22, 2019, 02:14 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerFeb 11, 2015Buy$1.305,9387,7195,938Feb 13, 2015, 04:15 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerFeb 11, 2015Buy$1.308,02510,4328,025Feb 13, 2015, 04:15 PM
CASMCAS MEDICAL SYSTEMS INCThomas, McNerney & Partners II, LLC10% OwnerFeb 11, 2015Buy$1.301,591,0372,068,3481,632,945Feb 13, 2015, 04:15 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II, LLCDirectorJan 28, 2015Sale$53.11730,00038,770,3004,835,731Jan 30, 2015, 02:17 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II, LLCDirectorJan 08, 2015Option Exercise$7.221,372,5729,904,4535,589,739Jan 12, 2015, 04:32 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II, LLCDirectorOct 09, 2014Option Exercise$6.6769,922466,7065,280,375Oct 14, 2014, 11:12 AM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II, LLCDirectorMay 14, 2014Option Exercise$6.5377,433505,5385,159,369Oct 01, 2014, 12:35 PM
ASPXAuspex Pharmaceuticals, Inc.Thomas, McNerney & Partners II, LLCDirectorFeb 10, 2014Buy$12.0082,475989,7005,113,567Oct 01, 2014, 12:33 PM
OCRXOcera Therapeutics, Inc.Thomas, McNerney & Partners II, LLC10% OwnerJul 15, 2013Option Exercise$6.001,751,39310,508,3581,751,393Jul 17, 2013, 06:41 PM
OCRXOcera Therapeutics, Inc.Thomas, McNerney & Partners II, LLC10% OwnerJul 15, 2013Option Exercise$6.00687,1764,123,056687,176Jul 17, 2013, 06:41 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.00524,2292,096,9161,407,316Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.001,9677,8685,280Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.005,47621,90414,700Nov 30, 2010, 12:26 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.006472,5886,297Nov 29, 2010, 09:43 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.003,17812,71256,094Nov 29, 2010, 09:43 PM
ZGNXZOGENIX, INC.Thomas, McNerney & Partners II, LLCSee Footnote (10)Nov 29, 2010Buy$4.00173,399693,5961,663,193Nov 29, 2010, 09:43 PM